Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Lynozyfic™ (linvoseltamab-gcpt) to treat adult ...

A high-stakes legal fight between Regeneron and Amgen over the blockbuster eye drug Eylea is putting the U.S. patent system ...

New enzyme discovery offers hope for millions of diabetes patients The scientists also ran molecular dynamics simulations to observe how the enzyme moves and reacts under different conditions.

Review Article Open access Published: 19 April 2018 Review Article TRPM2: a candidate therapeutic target for treating neurological diseases Jillian Corinne Belrose & Michael Frederick Jackson Acta ...

Scientists at The University of Texas at Arlington have identified a new enzyme that can be "turned off" to help the body maintain healthy cholesterol levels—a significant development that could ...

Scientists at The University of Texas at Arlington have identified a new enzyme that can be “turned off” to help the body maintain healthy cholesterol levels—a significant development that ...

Scientists at The University of Texas at Arlington have identified a new enzyme that can be "turned off" to help the body maintain healthy cholesterol levels-a significant development that could ...

Whether antiretroviral therapy (ART) is always completely suppressive, or HIV might continue to replicate at low levels despite ART in some people with HIV (PWH), is still debated. Here, we ...

Scientists map key enzymes behind locust swarming pheromone production by Bob Yirka, Phys.org edited by Lisa Lock, reviewed by Robert Egan Editors' notes ...

Newly identified enzymes offer a potential alternative to Yew tree sourcing of baccatin III, paving the way for sustainable large-scale biomanufacturing of paclitaxel.

The phase 3 IRAKLIA trial assesses subcutaneous isatuximab via on-body injector vs intravenous (IV) administration, in combination with pomalidomide and dexamethasone, in relapsed/refractory ...